Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170027 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
A Phase 3 study of Myocardial Ischemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT00170027 is a Phase 3 study of Myocardial Ischemia that has completed, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 2,129-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00170027, a Phase 3 study of Myocardial Ischemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive, non-contact diagnostic tool of obstructive coronary artery disease (CAD), and especially of cardiac ischemia. The overall objective of the present study is to demonstrate the efficacy of this MCG device in the diagnosis of lack of oxygen to an area of the heart (as in an Heart attack) in patients presenting with chest pain.
Conditions Studied
Interventions
- DEVICE Magnetocardiograph
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00170027
The ClinicalTrials.gov registry entry for NCT00170027 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,129-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (88% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myocardial Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Magnetocardiograph is the first listed.
NCT00170027 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00170027 about?
NCT00170027 is a clinical study titled "Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease". A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive, non-contact diagnostic tool of obstructive coronary artery disease (CAD), and especially of cardiac...
What is the current status of trial NCT00170027?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2003-07. Estimated completion is 2007-07.
What conditions does trial NCT00170027 study?
This clinical trial studies the following conditions: Myocardial Ischemia.
What interventions are being tested in trial NCT00170027?
The interventions under investigation include: Magnetocardiograph (DEVICE).
Who is sponsoring clinical trial NCT00170027?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00170027 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Electromechanical Mapping to Evaluate Heart Muscle
COMPLETED · Phase 3
-
Precision of the Magnetocardiographer for Data Aquision and Analysis.
COMPLETED · Phase 3
-
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
COMPLETED · Phase 3
-
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
COMPLETED · Phase 3
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.